Report cover image

Continuous Glucose Monitoring Devices Market

Published Jul 30, 2025
Length 190 Pages
SKU # CMI20302684

Description

Continuous glucose monitor (CGM) is a medical device used by people with diabetes to monitor blood sugar (glucose) on a continual basis, e.g. people with type I, type II diabetes, or other types of diabetes (e.g. gestational diabetes). Thus, with the increasing prevalence of diabetes across the globe, the demand for CGM devices is also increasing rapidly, worldwide.

Market Dynamics

Increasing prevalence of diabetes, growing geriatric population, increasing demand for continuous glucose monitors (CGM), increasing adoption of technologically advanced devices, and increasing awareness among people across the globe are major factors expected to augment the growth of thelobal continuous glucose monitoring devices market.

For instance, in May 2023, Health tech company, January AI, introduced a new generative artificial intelligence (AI)-enabled app to estimate and predict the glucose response of individuals to more than 32 Bn food items. The tool requires users to wear a CGM only once and it can function even if members are not using a CGM. The platform is designed to provide users with information such as glucose estimates, predictions and key insights on an ongoing basis. Users also receive insights on increasing fibre consumption, calorie recommendations, intermittent fasting, lowering glucose-spiking foods, and getting post-meal walks.

Key features of the study
  • This report provides in-depth analysis of the global continuous glucose monitoring devices market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global continuous glucose monitoring devices market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Medtronic, Dexcom, Inc., Abbott, Novo Nordisk A/S, Ypsomed, GlySens Incorporated, and F. Hoffmann-La Roche Ltd., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global continuous glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global continuous glucose monitoring device market.
Market Segmentation
  • Global Continuous Glucose Monitoring Devices Market, By Component
  • Sensors
  • Transmitters
  • Receivers
  • Global Continuous Glucose Monitoring Devices Market, By End User
  • Hospitals
  • Home care
  • Others
  • Global Continuous Glucose Monitoring Devices Market, By Geography
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Company Profiles
  • Medtronic
  • Dexcom, Inc.
  • Abbott
  • Novo Nordisk A/S
  • Ypsomed
  • GlySens Incorporated
  • Hoffmann-La Roche Ltd.

Table of Contents

190 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Component
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increasing prevalence of diabetes around the world
High cost of continuous glucose monitors
Increasing demand for continuous glucose monitors
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Continuous Glucose Monitoring Devices Market, By Component, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Sensors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Transmitters
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Receivers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Continuous Glucose Monitoring Devices Market, By End User, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home care
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Continuous Glucose Monitoring Devices Market, By Region, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
South Africa
North Africa
Central Africa
7. Competitive Landscape
Medtronic
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Dexcom, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Abbott
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Novo Nordisk A/S
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Ypsomed
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
GlySens Incorporated
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
F. Hoffmann-La Roche Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
8. Section
Research Methodology
About us
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.